Apollo Hospitals will leverage AI for Heart

New Delhi: Apollo Hospitals’ avowed aim of fighting against tsunami of Non Communicable Diseases (NCD) including cardiovascular disease has got a force multiplier in Microsoft. This partnership will lead to the prediction of the risk of cardiovascular disease in the Indian population.

As part of Microsoft’s AI Network for Healthcare initiative, Microsoft India and Apollo Hospitals Group have joined hands to set up a National Clinical Coordination Committee (NCCC) for AI-powered Cardiovascular Disease Risk Score API.

According to a press release NCCC will assist the core team at Apollo Hospitals and Microsoft by providing guidance on all cardiology and cardiovascular-related artificial intelligence projects; insights on developing clinical algorithm and treatment guidelines based on the inferences of national, multi-centre prospective study, a release said here.

‘The NCCC is a great step forward as part of our partnership with Apollo. We are also engaging global consortium partners to scale the AI-powered API (application programme interface),’ Microsoft, Cloud & Enterprise, Corporate Vice President, Anil Bhansali said,

‘We have already received approval for a pilot study and we hope that the findings will enable physicians to better understand the causes of CVDs in Indian population,’ he further said.

Speaking about the National Clinical Coordination Committee, Apollo Hospitals Group, Joint Managing Director, Sangita Reddy, said, ‘The NCCC will help us immensely in our fight against the rising tsunami of Non-Communicable Diseases (NCDs).’

According to the release, cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25 percent mortalities in the age group of 25 to 69 years. The condition also seems to affect Indians at least a decade earlier as compared to the Europeans.

Given the high prevalence of CVDs among Indians, Apollo Hospitals and Microsoft India, in 2018, launched the first ever AI-powered CVD Risk Score API, designed specifically to predict the risk of cardiovascular disease in the Indian population, it said.

Built on Microsoft Azure, the API aims to determine a more accurate CVD risk score for the Indian population taking into consideration risk factors including lifestyle attribute like diet, tobacco and smoking preferences, physical activity and psychological stress and anxiety.

Related Posts

CAHO Naa Patients Se Pyaar Hai

Calcutta:  As Mishty Doi hit it off with over 2000 first rate delegates and healthcare’s quality crusaders from home and abroad, Patient safety resolve took center stage as never before…

Ameera Shah, Prima Donna of Pathology, makes it to Powerful Healthcare Club NATHEALTH

New Delhi:  She came, she saw and she conquered- This classic line aptly sums up the meteoric rise and shine of 44 year old Ameera Shah, Promoter &MD of Metropolis…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

Organovo’s Drug Significantly Reduces Liver Fat In NASH Study